The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth

被引:182
|
作者
Cadwell, C [1 ]
Zambetti, GP [1 ]
机构
[1] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA
关键词
mgain-of-function; trans activation; apoptosis and tumorigenicity;
D O I
10.1016/S0378-1119(01)00696-5
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The tumor suppressor p53 plays a central role in the protection against DNA damage and other forms of physiological stress primarily by inducing cell cycle arrest or apoptosis. Mutation of p53, which is the most frequent genetic alteration detected in human cancers, inactivates these growth regulatory functions and causes a loss of tumor suppressor activity. In some cases, mutation also confers tumor-promoting functions, such as the transcriptional activation of genes involved in cell proliferation, cell survival and angiogenesis. Consequently, cells expressing some forms of mutant p53 show enhanced tumorigenic potential with increased resistance to chemotherapy and radiation. Our current understanding of these activities is summarized in this review. By dissecting out mechanistic differences between wild-type and mutant p53 activities, it may be possible to develop therapeutics that restore tumor suppressor function to mutant p53 or that selectively inactivate mutant p53 tumor-promoting functions. (C) 2001 Published by Elsevier Science B.V.
引用
收藏
页码:15 / 30
页数:16
相关论文
共 50 条
  • [41] Inhibition of mutant p53 phosphorylation at serine 15 or serine 315 partially restores the function of wild-type p53
    Sugikawa, E
    Yazaki, N
    Tsunoda, S
    Nakanishi, N
    Ohashi, M
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 261 (02) : 256 - 263
  • [42] Pontin, a new mutant p53-binding protein, promotes gain-of-function of mutant p53
    Zhao, Y.
    Zhang, C.
    Yue, X.
    Li, X.
    Liu, J.
    Yu, H.
    Belyi, V. A.
    Yang, Q.
    Feng, Z.
    Hu, W.
    [J]. CELL DEATH AND DIFFERENTIATION, 2015, 22 (11): : 1824 - 1836
  • [43] Pontin, a new mutant p53-binding protein, promotes gain-of-function of mutant p53
    Y Zhao
    C Zhang
    X Yue
    X Li
    J Liu
    H Yu
    V A Belyi
    Q Yang
    Z Feng
    W Hu
    [J]. Cell Death & Differentiation, 2015, 22 : 1824 - 1836
  • [44] p53 isoforms - A conspiracy to kidnap p53 tumor suppressor activity?
    V. Marcel
    P. Hainaut
    [J]. Cellular and Molecular Life Sciences, 2009, 66
  • [45] p53 isoforms - A conspiracy to kidnap p53 tumor suppressor activity?
    Marcel, V.
    Hainaut, P.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2009, 66 (03) : 391 - 406
  • [46] WILD-TYPE P53 SUPPRESSES GROWTH OF HUMAN PROSTATE-CANCER CELLS CONTAINING MUTANT P53 ALLELES
    ISAACS, WB
    CARTER, BS
    EWING, CM
    [J]. CANCER RESEARCH, 1991, 51 (17) : 4716 - 4720
  • [47] Modulation of MDR/MRP by wild-type and mutant p53
    Bähr, O
    Wick, W
    Weller, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (05): : 643 - 645
  • [48] p53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effect
    Blagosklonny, MV
    [J]. FASEB JOURNAL, 2000, 14 (13): : 1901 - 1907
  • [49] Mutant p53 oncogenicity: dominant-negative or gain-of-function?
    Stein, Yan
    Aloni-Grinstein, Ronit
    Rotter, Varda
    [J]. CARCINOGENESIS, 2020, 41 (12) : 1635 - 1647
  • [50] Gain-of-Function (GOF) Mutant p53 as Actionable Therapeutic Target
    Schulz-Heddergott, Ramona
    Moll, Ute M.
    [J]. CANCERS, 2018, 10 (06)